Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Women's Health
Published in: BMC Women's Health 1/2004

Open Access 01-08-2004 | Report

Women and Substance Abuse Problems

Authors: Renée A Cormier, Colleen Anne Dell, Nancy Poole

Published in: BMC Women's Health | Special Issue 1/2004

Login to get access

Abstract

Health Issues

Differences exist in the prevalence and physical health impacts of problem substance use among men and women. These differences are also found in the mental health and trauma events related to substance use, barriers to treatment and harm-reduction services and the impact of substance use on pregnancy and parenting. Data from the 2000–2001 Canadian Community Health Survey and Canada's Alcohol and Other Drugs Survey (1994) were used to explore this issue further.

Key Findings

While women use alcohol and illicit drugs at lower rates than men, the health impact of their use is significant, and in some cases greater than for men. Women are more likely to use prescribed psychoactive drugs (e.g. pain relievers, sleeping pills, tranquillizers) and most of these drugs have addictive potential and long-term negative consequences on health. Research collected from treatment centres in Canada show high rates of victimization experienced by women, which have implications for both their substance use treatment and improvement in mental health.

Data Gaps and Recommendations

Significant gaps exist in our knowledge on the level, type, and impact of substance use and the adequacy of programming for Canadian women. Information that might be used to guide prevention initiatives, such as the amount of alcohol that might safely be used in pregnancy and the incidence of fetal alcohol syndrome, related birth defects and developmental disabilities are unknown. Improved surveillance, sensitive and comprehensive screening for substance use problems, accessible treatment and harm reduction programming, and coordination with the mental health and violence fields are recommended.
Literature
1.
Health Canada: Straight facts about drugs and drug abuse. 2000, Ottawa: Health Canada
2.
National Institute on Alcohol Abuse and Alcoholism. Are women more vulnerable to alcohol's effects?. 1999, Alcohol Alert No 46:
3.
Deal SR, Gavaler JS: Are women more susceptible than men to alcohol-induced cirrhosis?. Alcohol Health Res World. 1994, 18 (3): 189-191.
4.
Mezey E, Kolman CJ, Diehl AM, Mitchell MC, Herlong HF: Alcohol and dietary intake in the development of chronic pancreatitis and liver disease in alcoholism. Am J Clin Nutr. 1988, 48 (1): 148-151.PubMed
5.
Lishman WA, Jacobson RR, Acker C: Brain damage in alcoholism: current concepts. Acta Med Scand Suppl. 1987, 717: 5-17.PubMed
6.
Mann K, Batra A, Gunthner A, Schroth G: Do women develop alcoholic brain damage more readily than men?. Alcohol Clin Exp Res. 1992, 16 (6): 1052-1056. 10.1111/j.1530-0277.1992.tb00698.x.PubMed
7.
Wuethrich B: Neurobiology: Does alcohol damage female brains more?. Science. 2001, 291 (55): 2077-2079. 10.1126/science.291.5511.2077.PubMed
8.
Camargo CA: Gender differences in the health effects of moderate alcohol consumption. In Alcohol and pleasure: a health perspective. Edited by: S. Peele S, Grant M. 1999, Philadelphia: Brunner/Mazel
9.
Dorgan JF, Baer DJ, Albert PS, Judd JT, Brown ED, Corle DK, Campbell WS, Hartman TJ, Tejpar AA, Clevidence BA, et al: Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst. 2001, 93 (9): 710-715. 10.1093/jnci/93.9.710.PubMed
10.
Longnecker MP, Berlin JA, Orza MJ, Chalmers TC: A meta-analysis of alcohol consumption in relation to risk of breast cancer. JAMA. 1988, 260: 625-656. 10.1001/jama.260.5.652.
11.
Lowenfels AB, Zevola SA: Alcohol and breast cancer: an overview. Alcohol Clin Exp Res. 1989, 13: 109-111. 10.1111/j.1530-0277.1989.tb00294.x.PubMed
12.
Reichman ME: Alcohol and breast cancer. Alcohol Health Res World. 1994, 18 (3): 182-183.
13.
Rabinovitz M, Van Thiel DH, Dindzans V, Gavaler JS: Endoscopic findings in alcoholic liver disease. Does gender make a difference?. Alcohol. 1989, 6: 465-468. 10.1016/0741-8329(89)90053-0.PubMed
14.
Hill SY: Vulnerability to the biomedical consequences of alcoholism and alcohol-related problems among women. In: Alcohol problems in women. Edited by: Wilsnack SC, Beckman LJ. 1984, New York: The Guilford Press
15.
16.
Health Canada: HIV and AIDS in Canada: Surveillance report to December 31, 2001. Ottawa: Division of HIV/AIDS Epidemiology and Surveillance, Bureau of HIV/AIDS, STD and TB, Centre for Infectious Disease Prevention and Control, Health Canada. 2001
17.
Tortu S, Beardsley M, Deren S, Williams M, McCoy HV, Stark M, Estrada A, Goldstein M: HIV infection and patterns of risk among women injectors and crack users in low and high sero-prevalence sites. AIDS Care. 2000, 12 (1): 65-76. 10.1080/09540120047486.PubMed
18.
Zilberman ML, Tavares H, Blume SB, el-Guebaly N: Substance use disorders: sex differences and psychiatric comorbidities. Can J Psychiatry. 2003, 48 (1): 5-13.PubMed
19.
Brems C, Namyniuk L: The relationship of childhood abuse history and substance use in an Alaska sample. Subst Use Misuse. 2002, 37 (4): 473-494. 10.1081/JA-120002806.PubMed
20.
Freeman RC, Collier K, Parillo KM: Early life sexual abuse as a risk factor for crack cocaine use in a sample of community recruited women at high risk for illicit drug use. Am J Drug Alcohol Abuse. 2002, 28 (1): 109-131. 10.1081/ADA-120001284.PubMed
21.
Ouimette PC, Kimerling R, Shaw J, Moos RH: Physical and sexual abuse among women and men with substance use disorders. Alcoholism Treatment Quarterly. 2000, 18 (3): 7-17. 10.1300/J020v18n03_02.
22.
Simpson TL, Miller WR: Concomitance between childhood sexual and physical abuse and substance use problems: a review. Clin Psychol Rev. 2002, 22 (1): 27-77. 10.1016/S0272-7358(00)00088-X.PubMed
23.
Briere J, Runtz M: Childhood sexual abuse: long-term sequelae and implications for psychological assessment. Journal of Interpersonal Violence. 1993, 8 (3): 312-330.
24.
Kolko DJ: Clinical monitoring of treatment course in child physical abuse: psychometric characteristics and treatment comparisons. Child Abuse Negl. 1996, 20 (1): 23-43. 10.1016/0145-2134(95)00113-1.PubMed
25.
Coker AL, Davis KE, Arias I, Desai S, Sanderson M, Brandt HM, Smith PH: Physical and mental health effects of intimate partner violence for men and women. Am J Prev Med. 2002, 23 (4): 260-268. 10.1016/S0749-3797(02)00514-7.PubMed
26.
Daley M, Argeriou M: Characteristics and treatment needs of sexually abused pregnant women in drug rehabilitation. J Subst Abuse Treat. 1997, 14: 191-196. 10.1016/S0740-5472(96)00123-7.PubMed
27.
Gil-Rivas V, Fiorentine R, Anglin MD: Sexual abuse, physical abuse, and posttraumatic stress disorder among women participating in outpatient drug abuse treatment. J Psychoactive Drugs. 1996, 28: 95-102.PubMed
28.
Gutierres SE, Todd M: The impact of childhood abuse on treatment outcomes of substance users. Professional Psychology: Research and Practice. 1997, 28 (4): 348-354. 10.1037//0735-7028.28.4.348.
29.
Kang SY, Magura S, Laudet A, Whitney S: Adverse effect of child abuse victimization among substance-using women in treatment. Journal of Interpersonal Violence. 1999, 14 (6): 650-657. 10.1177/088626099014006006.
30.
Najavits LM, Weiss RD, Shaw SR: The link between substance abuse and posttraumatic stress disorder in women: a research review. Am J Addict. 1997, 6: 273-283.PubMed
31.
Astley SJ, Clarren SK: Measuring the facial phenotype of individuals with prenatal alcohol exposure: correlations with brain dysfunction. Alcohol Alcohol. 2001, 36 (2): 147-159. 10.1093/alcalc/36.2.147.PubMed
32.
Health Canada: Best practices: fetal alcohol syndrome/fetal alcohol effects and the effects of other substance use during pregnancy. 2001, Ottawa: Health Canada
33.
Coffin CM, Hamilton MS, Pysher TJ, Bach P, Ashwood E, Schweiger J, Monahan D, Perry D, Rogers BB, Brugnara C, et al: Pediatric laboratory medicine: current challenges and future opportunities. Am J Clin Path. 2002, 117 (5): 683-690. 10.1309/C52D-BY0U-VXXU-R360.PubMed
34.
Boyd SC: Mothers and illicit drugs: transcending the myths. 1999, Toronto ON: University of Toronto Press Inc
35.
Chavkin W, Breitbart V: Substance abuse and maternity: the United States as a case study. Addiction. 1997, 92 (9): 1201-1205. 10.1046/j.1360-0443.1997.929120121.x.PubMed
36.
Paltrow LM: Punishing women for their behavior during pregnancy: an approach that undermines the health of women and children. In: Drug addiction research and the health of women. Edited by: Wetherington CL, Roman AB. 1998, Rockville MD: National Institute on Drug Abuse, 476-501.
37.
Rutman D, Callahan M, Lundquist A, Jackson S, Field B: Substance use and pregnancy: conceiving women in the policy-making process. 2001, Ottawa: Status of Women Canada
38.
Finkelstein N, Kennedy C, Thomas K, Kearns M: Gender specific substance abuse treatment. Arlington VA: The National Women's Resource Center for the Prevention and Treatment of Alcohol, Tobacco, and Other Drug Abuse and Mental Illness. 1997
39.
Copeland J: A qualitative study of barriers to formal treatment among women who self-managed change in addictive behaviours. J Subst Abuse Treat. 1997, 4 (2): 183-190. 10.1016/S0740-5472(96)00108-0.
40.
Health Canada: Best practices: treatment and rehabilitation for women with substance use problems. 2001, Ottawa, ON: Health Canada
41.
Grella CE: Services for perinatal women with substance abuse and mental health disorders: the unmet need. J Psychoactive Drugs. 1997, 29 (1): 67-78.PubMed
42.
Padayachee A: Hidden health burden: alcohol-abusing women, misunderstood and mistreated. Int J Drug Policy. 1998, 9 (1): 57-62. 10.1016/S0955-3959(97)00013-3.
43.
Poole N, Isaac B: Apprehensions: barriers to treatment for substance-using mothers. Vancouver: British Columbia Centre of Excellence for Women's Health. 2001
44.
Blum LN, Nielsen NH, Riggs JA: Alcoholism and alcohol abuse among women: report of the Council on Scientific Affairs. Journal of Women's Health. 1998, 7 (7): 861-871.PubMed
45.
Corse S, McHugh M, Gordon S: Enhancing provider effectiveness in treating pregnant women with addictions. J Subst Abuse Treat. 1995, 12 (1): 3-12. 10.1016/0740-5472(94)00081-6.PubMed
46.
Gehshan S: Missed opportunities for intervening in the lives of pregnant women addicted to alcohol or other drugs. J Am Med Wom Assoc. 1995, 50 (5): 160-163.PubMed
47.
Poole N: Evaluation report of the Sheway Project for high-risk pregnant and parenting women. Vancouver: British Columbia Centre of Excellence for Women's Health. 2000
48.
49.
Statistics Canada: Canadian Community Health Survey Cycle 1.1. Ottawa. 2001
50.
Single EW, Mackenzie D: Canadian profile: alcohol, tobacco, and other drugs. 1997, Ottawa: Canadian Centre on Substance Abuse
51.
Single EW, Robson L, Xie X, Rehm J: The economic costs of substance abuse in Canada. 1996, Ottawa: Canadian Centre on Substance Abuse
52.
Statistics Canada: Canada's Alcohol and Other Drugs Survey. 1996, Ottawa: Statistics Canada, Canadian Centre for Health Information
53.
Centre for Addiction and Mental Health: Canadian Campus Survey, 1998. 2000, Toronto: Centre for Addiction and Mental Health
54.
Taylor S, McCracken CF, Wilson KC, Copeland JR: Extent and appropriateness of benzodiazepine usage. Results from an elderly urban community. Br J Psychiatry. 1998, 173: 433-438.PubMed
55.
Celentanto DD, McQueen DV: Multiple substance abuse among women with alcohol-related problems. 1984, New York: The Guilford Press
56.
Gabe J: Personal troubles and public issues: the sociology of long-term tranquilliser use. In: Understanding tranquilliser use: the role of the social sciences. Edited by: Gabe J. 1991, London: Tavistock/Routledge, 31-47.
57.
Reed BG: Developing women-sensitive drug dependence treatment services: Why so difficult?. J Psychoactive Drugs. 1987, 19 (2): 151-164.PubMed
58.
Jorm AF, Grason D, Creasey H, Waite L, Broe GA: Long term benzodiazepine use by elderly people living in the community. Aust N Z J Public Health. 2000, 24 (1): 7-10.PubMed
59.
Sarkisian CA, Lui H, Gutierrez PR, Seeley DG, Cummings SR, Mangione CM: Modifiable risk factors predict functional decline among older women: a prospectively validated clinical prediction tool. The study of the Osteoporotic Fractures Research Group. J Am Geriatr Soc. 2000, 48 (2): 170-178.PubMed
60.
Ashton H: Benzodiazepine dependency. In: Handbook of psychology and medicine. Edited by: Baum A, Newman S, Weinman J, West R, MacManus C. 1997, Cambridge: Cambridge University Press, 376-380.
61.
Cumming RG, Klineberg RJ: Psychotropics, thiazide diuretics and hip fractures in the elderly. Med J Aust. 1993, 158 (6): 414-417.PubMed
62.
Herings RM, Stricker BH, de Boer A, Bakker A, Sturmans F: Benzodiazepines and risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med. 1995, 155 (16): 1801-1807. 10.1001/archinte.155.16.1801.PubMed
63.
Centre for Addiction and Mental Health: Ontario Student Drug Use Survey. 1999, Toronto: Centre for Addiction and Mental Health
64.
Cormier RA: Predicting treatment outcome in chemically dependent women: a test of Marlatt and Gordon's relapse model. 2000, Unpublished doctoral dissertation. Windsor: University of Windsor
65.
Chappell M: Relief at what cost? Women with disabilities and substance use/misuse: tobacco, alcohol and other drugs. 1995, Ottawa: Health Canada
66.
Copans S, MacNamee H, Burkle F, Goodstein R: Special populations. In: Loosening the grip: handbook of alcohol information. Edited by: Kinney J. 2000, Boston MA: McGraw-Hill
67.
Galaif ER, Nyamathi AM, Stein JA: Psychosocial predictors of current drug use, drug problems, and physical drug dependence in homeless women. Addict Behav. 1999, 24 (6): 801-814. 10.1016/S0306-4603(99)00038-6.PubMed
68.
Guthrie BJ, Boyd CJ, Hughes T: Drugs and girls: What do we know?. Journal of Addictions Nursing. 1997, 9 (2): 64-71.
69.
Health Canada: Horizons Two – Canadian women's alcohol and other drug use: increasing our understanding. 1995, Ottawa: Health Canada
70.
Health Canada: Rural women and substance use: issues and implications for programming. 1996, Ottawa: Health Canada
71.
Health Canada: Immigrant women and substance use: current issues, programs and recommendations. 1996, Ottawa: Health Canada
72.
Li L, Ford J: Illicit drug use by women with disabilities. Am J Drug Alcohol Abuse. 1998, 24 (3): 405-418.PubMed
73.
Mulvihill M, Mailloux L, Atkin W: Advancing policy and research responses to immigrant and refugee women's health in Canada. 2001, Centres of Excellence for Women's Health
74.
Metadata
Title
Women and Substance Abuse Problems
Authors
Renée A Cormier
Colleen Anne Dell
Nancy Poole
Publication date
01-08-2004
Publisher
BioMed Central
Published in
BMC Women's Health / Issue Special Issue 1/2004
Electronic ISSN: 1472-6874
DOI
https://doi.org/10.1186/1472-6874-4-S1-S8

Other articles of this Special Issue 1/2004

BMC Women's Health 1/2004 Go to the issue

Report

Other Gynecologic Cancers: endometrial, ovarian, vulvar and vaginal cancers

Report

Personal Health Practices

Report

Perimenopausal and Postmenopausal Health

Introduction

Women's Health Surveillance Report: Introduction

Report

Integrating Socio-Economic Determinants of Canadian Women's Health

Report

Contraception